Welcome to our dedicated page for DTRTU news (Ticker: DTRTU), a resource for investors and traders seeking the latest updates and insights on DTRTU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DTRTU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DTRTU's position in the market.
On January 30, 2023, stockholders of DTRT Health Acquisition Corp. (NASDAQ: DTRTU, DTRT, DTRTW) approved a Charter Amendment allowing the redemption of all issued Class A common stock before the current termination date of March 7, 2023. The Company will redeem shares due to the inability to complete a business combination by the new Amended Termination Date. This Mandatory Redemption is expected to occur around February 6, 2023, resulting in the dissolution and liquidation of the Company, with no redemption rights for warrants. The Company has notified Nasdaq for a trading suspension and intends to file a Form 25 for delisting.
Consumer Direct Holdings, Inc. (CDH) and DTRT Health Acquisition Corp. (DTRT) announced the filing of a Registration Statement with the SEC regarding their proposed business combination. A merger agreement was signed on September 28, 2022, with completion expected in Q1 2023, subject to stockholder approval and regulatory clearance. The transaction values CDH at approximately $691 million. Post-merger, the new entity, expected to be called Consumer Direct Care Network, Inc., will trade under new stock symbols on Nasdaq.
Consumer Direct Holdings (CDH) and DTRT Health Acquisition Corp (DTRT) have announced a definitive merger deal, positioning CDH to become a public company with an enterprise valuation of
DTRT Health Acquisition Corp. (NASDAQ: DTRTU) announced that starting October 25, 2021, holders of its 23 million units from the initial public offering can separate their shares of Class A common stock and warrants for individual trading. The separated shares will trade under the symbols DTRT and DTRTW on Nasdaq, while unsplit units will continue under DTRTU. The offering was led by Cantor Fitzgerald and Odeon Capital Group. No fractional warrants will be issued during this process.
DTRT Health Acquisition Corp. has completed its initial public offering of 23,000,000 units at $10.00 each, with 3,000,000 units sold through an over-allotment option. The units began trading on NASDAQ under the symbol 'DTRTU' on September 2, 2021. Each unit contains one share of Class A common stock and one-half of a warrant, which can be exercised at $11.50 per share. The company aims to pursue business combinations primarily in the healthcare sector, focusing on home and community-based services.
DTRT Health Acquisition Corp. has priced its initial public offering (IPO) at $10.00 per unit, with 20,000,000 units being offered. The IPO is set to begin trading on NASDAQ under the ticker symbol 'DTRTU' on September 2, 2021. Each unit comprises one share of Class A common stock and one-half of one redeemable warrant, with each whole warrant exercisable at $11.50 per share. The offering is expected to close on September 7, 2021, pending customary closing conditions. Cantor Fitzgerald & Co. is the sole bookrunner for the IPO.